Two Sigma Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,500
| Closed | -$800K | – | 1400 |
|
|
2024
Q4 | $800K | Sell |
4,500
-91,900
| -95% | -$16.9M | 0.11% | 205 |
|
|
2024
Q3 | $19M | Sell |
96,400
-37,400
| -28% | -$6.98M | 0.32% | 58 |
|
|
2024
Q2 | $22.9M | Sell |
133,800
-134,100
| -50% | -$22.2M | 0.28% | 66 |
|
|
2024
Q1 | $48.8M | Buy |
267,900
+86,600
| +48% | +$14.9M | 0.47% | 31 |
|
|
2023
Q4 | $28.1M | Sell |
181,300
-85,200
| -32% | -$12.4M | 0.27% | 68 |
|
|
2023
Q3 | $39.7M | Buy |
266,500
+84,300
| +46% | +$12.4M | 0.42% | 34 |
|
|
2023
Q2 | $24.5M | Sell |
182,200
-18,200
| -9% | -$2.67M | 0.37% | 48 |
|
|
2023
Q1 | $31.9M | Buy |
200,400
+31,300
| +19% | +$4.79M | 0.64% | 17 |
|
|
2022
Q4 | $27.3M | Buy |
169,100
+5,700
| +3% | +$874K | 0.82% | 7 |
|
|
2022
Q3 | $21.9M | Sell |
163,400
-19,000
| -10% | -$2.73M | 0.66% | 8 |
|
|
2022
Q2 | $27.9M | Buy |
182,400
+127,200
| +230% | +$19.4M | 0.99% | 3 |
|
|
2022
Q1 | $8.95M | Buy |
+55,200
| New | +$8.02M | 0.32% | 43 |
|
|
2021
Q4 | – | Sell |
-33,800
| Closed | -$3.65M | – | 1510 |
|
|
2021
Q3 | $3.65M | Sell |
33,800
-1,700
| -5% | -$194K | 0.11% | 163 |
|
|
2021
Q2 | $4M | Buy |
35,500
+31,400
| +766% | +$3.54M | 0.12% | 117 |
|
|
2021
Q1 | $444K | Sell |
4,100
-26,500
| -87% | -$2.83M | 0.02% | 316 |
|
|
2020
Q4 | $3.28M | Buy |
30,600
+17,900
| +141% | +$1.72M | 0.08% | 159 |
|
|
2020
Q3 | $1.11M | Sell |
12,700
-34,400
| -73% | -$3.24M | 0.02% | 328 |
|
|
2020
Q2 | $4.62M | Sell |
47,100
-60,700
| -56% | -$5.34M | 0.1% | 108 |
|
|
2020
Q1 | $8.21M | Sell |
107,800
-127,500
| -54% | -$10.9M | 0.18% | 60 |
|
|
2019
Q4 | $20.8M | Sell |
235,300
-82,200
| -26% | -$6.82M | 0.14% | 93 |
|
|
2019
Q3 | $24M | Sell |
317,500
-57,800
| -15% | -$3.96M | 0.22% | 52 |
|
|
2019
Q2 | $27.3M | Buy |
375,300
+251,800
| +204% | +$19.8M | 0.29% | 42 |
|
|
2019
Q1 | $9.95M | Sell |
123,500
-224,700
| -65% | -$18.4M | 0.09% | 99 |
|
|
2018
Q4 | $32.1M | Buy |
348,200
+3,800
| +1% | +$334K | 0.39% | 27 |
|
|
2018
Q3 | $32.6M | Sell |
344,400
-69,200
| -17% | -$6.56M | 0.21% | 54 |
|
|
2018
Q2 | $38.3M | Sell |
413,600
-215,100
| -34% | -$21M | 0.19% | 67 |
|
|
2018
Q1 | $59.5M | Buy |
628,700
+607,200
| +2,824% | +$66.7M | 0.33% | 38 |
|
|
2017
Q4 | $2.08M | Buy |
+21,500
| New | +$2.03M | 0.06% | 258 |
|
Other funds holding ABBV
Two Sigma Securities's ABBV Position: Q3 2025 in Review
Two Sigma Securities sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 15,656 shares — an estimated $2.91M sold.
Two Sigma Securities first reported a position in ABBV in Q3 2015 and held it in 21 quarters. The position peaked at $5.49M in Q1 2018. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Two Sigma Securities reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Two Sigma Securities sold 15,656 AbbVie shares in Q3 2025, an estimated $2.91M.
- Two Sigma Securities first reported a position in AbbVie in Q3 2015 and held it in 21 quarters.
- Two Sigma Securities's AbbVie position peaked at $5.49M in Q1 2018.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.